Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients

Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients

Bibliographic Details
Main Authors:	Catherine Cordonnier, Montserrat Rovira, Johan Maertens, Oliver A Cornely, Per Ljungman, Hermann Einsele
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2011-02-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/5892

Similar Items

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
by: Catherine Cordonnier, et al.
Published: (2010-10-01)

Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients (reply)
by: Corrado Girmenia
Published: (2011-02-01)

Antifungal Prophylaxis in Solid Organ Transplant Recipients
by: Şebnem ŞENOL, et al.
Published: (2015-12-01)

Voriconazole as a secondary prophylaxis for cryptococcal meningitis during hematopoietic stem cell transplantation
by: Emiko Kashima, et al.
Published: (2021-01-01)

Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
by: Oliveira J.S.R., et al.
Published: (2002-01-01)

Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
by: Songji Tu, et al.
Published: (2023-11-01)

Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
by: Peipei Ye, et al.
Published: (2022-05-01)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?
by: Jannik Stemler, et al.
Published: (2022-07-01)

Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
by: Ahmed M. Alkhunaizi, et al.
Published: (2018-01-01)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
by: Santiago Grau, et al.
Published: (2015-10-01)

Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients
by: Zhi-Hua Sun, et al.
Published: (2025-01-01)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
by: Elizabeth Posney, PharmD, et al.
Published: (2024-05-01)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022-12-01)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
by: Yi‐Chang Zhao, et al.
Published: (2021-03-01)

Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT
by: Milo Gatti, et al.
Published: (2024-07-01)

Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
by: Allan S MacDonald, et al.
Published: (1993-01-01)

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
by: Vaibhav Agrawal, et al.
Published: (2020-01-01)

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum
by: B. Luijk, et al.
Published: (2011-01-01)

Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient
by: Olivier Paccoud, et al.
Published: (2023-06-01)

Thoracic periosteal reaction secondary to voriconazole use in an adult transplant patient
by: Anisha N. Shetty, MD, et al.
Published: (2024-01-01)

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
by: Currie, A, et al.
Published: (2010)

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients
by: Per Ljungman, et al.
Published: (2011-08-01)

Disseminated Trichosporon asahii infection in a combined liver‐kidney transplant recipient successfully treated with voriconazole
by: Ranjit Sah, et al.
Published: (2019-09-01)

Antifungal prophylaxis in stem cell transplantation centers in Turkey
by: Hamdi Akan
Published: (2011-12-01)

Antifungal prophylaxis in stem cell transplantation centers in Turkey
by: Hamdi Akan
Published: (2011-12-01)

Drugs in development for prophylaxis of rejection in kidney-transplant recipients
by: Sanders ML, et al.
Published: (2015-08-01)

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study
by: Alexander Rombauts, et al.
Published: (2023-04-01)

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
by: Kaiwen Chen, et al.
Published: (2018-08-01)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
by: Karthaus M
Published: (2011-04-01)

Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy
by: Sviatlana Kandaurava, et al.
Published: (2020-12-01)

ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: Alessandro Busca, et al.
Published: (2016-09-01)

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis
by: Chris David Lauruschkat, et al.
Published: (2023-05-01)

Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
by: Katherine N Ward, et al.
Published: (2019-11-01)

Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
by: Florian Reizine, et al.
Published: (2023-02-01)

Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study
by: Weili Wang, et al.
Published: (2024-06-01)

Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
by: Cornelia Geisler Crone, et al.
Published: (2023-11-01)

An appraisal of antifungal impacts of nano-liposome containing voriconazole on voriconazole-resistant Aspergillus flavus isolates as a groundbreaking drug delivery system
by: Parviz Hassanpour, et al.
Published: (2020-03-01)

Voriconazole-induced periostitis post lung transplantation
by: Orla M. Murray, Bsc, et al.
Published: (2022-05-01)

Paecilomyces Pneumonia Despite Voriconazole Prophylaxis: A Case Report and Literature Review
by: Abuzar A Asif, et al.
Published: (2021-06-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01)